NYSE issues a pre-market daily advisory direct from the trading floor.

NEW YORK, March 24, 2026 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

Ashley Mastronardi delivers the pre-market update on March 24th

• Markets are little changed after coming off a winning session on Monday, amid optimism that a resolution to the Iran conflict could be in sight.
• The ‘Where You Work Matters’ list, featuring nearly 200 NYSE-listed companies, has been revealed and Rajiv Chandrasekaran of the Schultz Family Foundation will join NYSE Live to dive deeper into the report.
• The Hill and Valley Forum commences in Washington, D.C., bringing together government and technology leaders to discuss industry and innovation.
• ‘Tomorrow’s Titans: Pitch. Defend. Win.,’ presented by NightDragon, NYSE, and PwC, will film at the RSAC Conference for the first time today.

Opening Bell
Banco Macro (NYSE: BMA) celebrates its 20^th anniversary of listing

Closing Bell
Dana Incorporated (NYSE: DAN) hosts its Capital Markets Day

For market insights, IPO activity, and today’s opening bell, download the NYSE TV App: TV.NYSE.com

Jacobs at the NYSE on March 23rd.

Video – https://mma.prnasia.com/media2/2941112/NYSE_March_24_Market_Update.mp4 
Photo – https://laotiantimes.com/wp-content/uploads/2026/03/jacobs_nyse_march_23.jpg 
Logo – https://laotiantimes.com/wp-content/uploads/2026/03/new_york_stock_exchange_log-15.jpg

HANOI, Vietnam, March 24, 2026 /PRNewswire/ — The copy trading landscape is evolving rapidly, with retail investors in various markets increasingly exploring ways to participate in financial markets. Platforms that combine robust infrastructure with a vibrant ecosystem of signal providers are uniquely positioned to capture market share.

Vantage, a global multi-asset trading platform, continues to expand its copy trading ecosystem, offering traders and signal providers a seamless way to mirror top-performing traders in real time. The platform’s secure infrastructure and access to diverse asset classes make it a trusted choice for participants across multiple markets.

The adoption of copy trading has accelerated across strategic markets, fueled by demand for accessible, automated trading solutions. With competitors consolidating or exiting certain regions, traders are exploring alternative platforms that provide reliability, transparency, and earning potential.

Vantage continues to expand its copy trading ecosystem and offers platform features for traders and signal providers. With a growing community of over 600,000 copiers and nearly 100,000 signal providers, Vantage continues to expand its copy trading ecosystem across key market regions, offering several unique features:

• Daily updates and settlements allow participants to track activity efficiently.

• Flexible leverage options support traders in managing their trading approach effectively.

• Multi-tier IB structure encourages collaboration and growth within the ecosystem.

Signal providers can share strategies and insights with followers, contributing to a thriving community while leveraging Vantage’s infrastructure to reach a wider audience.

Vantage’s copy trading ecosystem has also earned repeated recognition, receiving the “Best-in-Class Social Copy Trading” award from Forexbrokers.com for six consecutive years (2021–2026). This track record reinforces Vantage’s commitment to providing a reliable, innovative, and user-focused trading experience.

By offering a scalable, secure, and transparent environment, Vantage supports traders and signal providers to explore new opportunities while fostering a vibrant ecosystem of partners. As adoption continues to grow in key market regions, Vantage remains focused on providing advanced technology, flexible trading options, and a connected ecosystem that meets the evolving needs of participants.

To learn more about Vantage’s award-winning services, visit Vantage Markets. Services may not be available in all jurisdictions.

About Vantage

Vantage Markets (or Vantage) is a multi-asset CFD broker offering clients access to a nimble and powerful service for trading Contracts for Difference (CFDs) products, including Forex, Commodities, Indices, Shares, ETFs, and Bonds.

With over 16 years of market experience, Vantage transcends the role of broker, providing a reliable trading platform, an award-winning mobile trading app, and a user-friendly trading platform that provides clients access to trading opportunities.

trade smarter @vantage

RISK WARNING: CFDs are complex instruments and carry a high risk of losing money rapidly due to leverage. Ensure you understand the risks before trading.

Disclaimer: This content is for informational purposes only and does not constitute financial or investment advice. It is not intended for residents of jurisdictions where CFD trading is restricted or prohibited.

• Expanded treatment and visualization capabilities within posterior care workflows: ICGA for ZEISS CLARUS 700 offers FA + ICG simultaneous capture to help support clinical assessment and streamline the diagnostic process; ZEISS VISULAS green, now available with ZEISS SLT, offers dependable retinal photocoagulation.
• Ergonomic diagnostic tools support efficient workflows and streamlined examination steps: ZEISS VISUREF 600 wavefront refraction consolidates multiple assessments to support efficiency and reliable results; ZEISS VISUCORE 500 all-in-one combined refraction unit helps save space and increase efficiency.
• Enhanced therapeutic care improves ZEISS Cataract Workflow: ZEISS VISULAS yag new-generation, therapeutic laser provides anterior segment photodisruption.
• Consistent clinical review with new digital data management offerings: ZEISS FORUM subscription packages offer an agile, integrated solution that grows with the clinic.

JENA, Germany and TORONTO, March 24, 2026 /PRNewswire/ — ZEISS Medical Technology, one of the world’s leading medical technology companies, announced today the expansion of clinical workflows for ophthalmology and optometry in Canada, including advanced diagnostic equipment, new-generation laser treatment devices, and efficient digital workflow tools and enhancements. ZEISS innovations will be showcased at the Ontario Association of Optometrists conference from March 27 – 29, in Ottawa, ON, and at the Canadian Ophthalmological Society conference from June 18 – 21, in Montréal, QC, Canada.

ZEISS VISUCORE 500

“ZEISS is proud to expand access to advanced therapeutic lasers, diagnostic technologies, and digital workflow solutions in Canada. These innovations help enhance patient care across our clinical workflows and reflect our commitment to supporting eye care professionals with integrated solutions which offer tools that support them in making informed care decisions, improving practice efficiency, and delivering better outcomes for patients across the country,” says Bryan Rossi, President of ZEISS Canada.

Expanded treatment and visualization capabilities within posterior care workflows

ZEISS has added diagnostic and therapeutic features for use within established clinical workflows. Supporting clinical assessment with advanced imaging and workflow tools, the CLARUS^® 700 with ICGA provides high-resolution early-phase to late-phase ultra-widefield imaging for both retina and glaucoma care. New features include standalone ICG, simultaneous FA-ICG capture, and an added movie mode for all angiography modalities: standalone FA, standalone ICG, and simultaneous FA-ICG. Additionally, this year marks the 100-year anniversary of advancements in ZEISS fundus imaging. In 1926, ZEISS and Johan Nordenson released the first commercially available fundus camera, laying the foundation for a century of innovation in ocular imaging technology.

Now available with ZEISS SLT as a first-line treatment of primary open-angle glaucoma, the VISULAS^® green from ZEISS delivers dependable retinal photocoagulation to support procedures for diabetic retinopathy, retinal tears, and other chorioretinal indications. Helping clinicians work quickly and comfortably, the ZEISS VISULAS green allows clinicians to monitor parameters such as laser power, pulse duration, and spot size without taking their eyes off the patient or the treatment area. While viewing parameters in the eyepiece, the ZEISS VISULAS green has a TouchControl center switch to adjust laser energy or other settings simultaneously. Additionally, the therapeutic laser automatically generates treatment summaries that can be exported directly to the ZEISS FORUM data management system for a paperless record. The ZEISS VISULAS green is compatible with digital workflow tools such as ZEISS FORUM.  

Ergonomic diagnostic tools support efficient workflows and streamlined examination steps

Now available in Canada, the ZEISS VISUREF 600 and ZEISS VISUCORE 500 refraction devices support a streamlined workflow for reliable refraction diagnoses in optometry clinics. The VISUREF^® 600 from ZEISS consolidates multiple assessments into one to offer refraction workflow tools from fast, reliable pretests to data-driven subjective refraction—delivering higher diagnostic confidence, more consistent prescriptions, and a cohesive, step wise workflow experience from first measurement to tailored lens consultation. Intuitive ergonomics and scalable configurations help standardize protocols across teams and boost throughput, while modern connectivity helps elevate patient satisfaction and trust in clinical outcomes. 

Additionally, the ZEISS VISUCORE 500 provides an all-in-one combined refraction unit that delivers space-saving refraction with a footprint of under 0.8 m² solution to help eye care professionals streamline their workflow, standardize testing, and increase patient comfort and workflow convenience —from objective measurements through guided subjective refraction. By consolidating key steps and enabling seamless data flow to practice software, it’s designed to support efficient workflows and streamlined examination steps. The device offers tools that support clinicians in making informed care decisions, more efficient use of clinic space and staff, and a cohesive, step wise workflow experience for clinicians and patients.

Enhancing anterior patient care within the ZEISS Cataract Workflow

Expanding ophthalmologists’ treatment capabilities within the cataract workflow in Canada, ZEISS now offers the VISULAS^® yag from ZEISS new generation therapeutic laser enabling intuitive ergonomics and streamlined workflows for confident anterior segment photodisruption. The system empowers clinicians with versatile, laser-based treatment capabilities, optimized workflows, and evidence-backed performance that aligns with ZEISS’s commitment to patient-centric innovation.

The ZEISS VISULAS yag delivers precise laser photodisruption for posterior capsulotomy and iridotomy, with a compact, application-based workstation that offers intuitive focus-shift targeting and selectable aiming beams to streamline clinical workflows— designed with patient comfort and workflow convenience in mind. The ZEISS VISULAS yag is compatible with digital workflow tools such as ZEISS FORUM.

Streamlined digital workflow supports consistent clinical review

Now available as a subscription package in Canada, FORUM^® from ZEISS helps clinics streamline their workflow, centralize ophthalmic data to support consistent clinical review, and simplify a clinic’s digital environment. It enables a fully electronic workflow where clinicians can send patient demographics automatically to the instruments for a paperless workflow. It also facilitates clinical case visualization by preparing ophthalmic data and images to better support patient care. Additionally, it integrates conveniently into a clinic’s existing IT infrastructure using established standards as well as customized tools, ensuring patient record consistency.

With the ZEISS FORUM subscription package, clinics utilize the company’s leading data management system to receive an agile, integrated solution that grows with the clinic. With the subscription package, clinics benefit from unlimited device licenses and connections including non-ZEISS devices, lower upfront costs with predictable payments, access to the latest features and improvements, and ongoing service and expert support.

“ZEISS FORUM Glaucoma Workspace has significantly strengthened our clinical workflow, enabling faster, more confident decisions in both initiating and managing glaucoma. Its ability to centralize diagnostic data enhances clarity and collaboration within our team,” says Dr. Megan Sear, Licensed Optician at Bay Vision Care, Ontario, Canada. 

For more information about product availability in Canada, please visit the ZEISS Medical Technology Canada website or speak to your local ZEISS representative.

Not all products, services or offers are approved or offered in every market and approved labeling and instructions may vary from one country to another. For country-specific product information, see the appropriate country website. Product specifications are subject to change in design and scope of delivery as a result of ongoing technical development. The statements of the healthcare professionals reflect only their personal opinions and experiences and do not necessarily reflect the opinion of any institution that they are affiliated with. The healthcare professionals alone are responsible for the content of their experience reported and any potential resulting infringements. Carl Zeiss Meditec AG and its affiliates to not have clinical evidence supporting the opinions and statements of the health care professionals nor accept any responsibility or liability of the healthcare professionals’ content. The healthcare professionals have a contractual or other financial relationship with Carl Zeiss Meditec AG and its affiliates and have received financial support.

www.zeiss.com/newsroom 

Company Profile

Carl Zeiss Meditec AG (ISIN: DE0005313704), which is listed on the TecDAX and SDAX of the German stock exchange, is one of the world’s leading medical technology companies. The Company supplies innovative technologies and application-oriented solutions designed to help doctors improve the quality of life of their patients. The Company offers complete solutions, including implants and consumables, to diagnose and treat eye diseases. The Company creates innovative visualization solutions in the field of microsurgery. With 5,784 employees worldwide, the Group generated revenue of €2,228m in fiscal year 2024/25 (to 30 September).

The Group’s head office is located in Jena, Germany, and it has subsidiaries in Germany and abroad; more than 50 percent of its employees are based in the USA, Japan, Spain and France. The Center for Application and Research (CARIn) in Bangalore, India and the Carl Zeiss Innovations Center for Research and Development in Shanghai, China, strengthen the Company’s presence in these rapidly developing economies. Around 39 percent of Carl Zeiss Meditec AG’s shares are in free float. Approx. 59 percent are held by Carl Zeiss AG, one of the world’s leading groups in the optical and optoelectronic industries.

For further information visit: www.zeiss.com/med

VISULAS® green from ZEISS

VISULAS® yag from ZEISS

VISUREF® 600 from ZEISS

CLARUS® 700 from ZEISS with ICGA

FORUM® from ZEISS

• COOL 68 magnetic keyboard and A950GM mouse lead brand upgrade as esports and social commerce expand

LOS ANGELES, March 24, 2026 /PRNewswire/ — Global gaming peripherals manufacturer DAREU celebrates its 20th anniversary with a brand upgrade. The company also launches its official U.S. storefront on TikTok, expanding its reach to American gamers.

This move coincides with continued growth in the global esports market. According to Newzoo, esports audiences are projected to exceed 640 million viewers in the coming years, while demand for high-performance gaming peripherals rises alongside competitive and content-driven gaming culture.

Social commerce is rapidly becoming a key channel for consumer electronics brands. With in-app video discovery and direct purchasing, TikTok allows hardware companies to connect with younger audiences and gaming creators more efficiently.

Magnetic Keyboards: A New Trend

Magnetic switch systems, also called Hall-effect keyboards, use sensors to detect key actuation, enabling adjustable actuation points and rapid trigger functionality. Keys reset instantly, offering faster input for competitive games such as FPS and tactical esports titles.

As part of its anniversary lineup, DAREU introduces the COOL 68 magnetic keyboard, featuring rapid trigger functionality, customizable actuation, and a compact layout suitable for modern gaming setups.

New Products for Players

Alongside the COOL 68, the company launches the A950GM gaming mouse, equipped with the PixArt 3395 sensor and a lightweight wireless design for competitive gameplay.

Both products are available through the newly launched DAREU US Shop on TikTok, where players can discover them via creator reviews, setup showcases, and gameplay demonstrations.

“Gamers increasingly discover hardware through creators and short-form content,” said a DAREU spokesperson. “Our TikTok Shop brings products directly to the communities shaping gaming culture today.”

20-Year Evolution 

Founded in 2006, DAREU has spent two decades developing keyboards, mice, and accessories for global markets. Its integrated design, R&D, and manufacturing capabilities enable proprietary technologies at scale.

The TikTok store launch marks an early step in DAREU’s broader strategy, expanding internationally and engaging a new generation of competitive and casual gamers. Consumers can discover the store by searching “DAREU USA SHOP“ on TikTok.

About DAREU 

Founded in 2006, DAREU is a global gaming peripherals brand specializing in keyboards, gaming mice, and esports accessories. With over 20 years of design and manufacturing experience, the company delivers hardware for competitive players and gaming enthusiasts worldwide.

For more information, visit

www.dareu.com

New platform capabilities enable enterprises to provision and govern AI agent access to enterprise data in real time — without impersonation, standing privileges, or ticket-driven delays

BOSTON, March 24, 2026 /PRNewswire/ — Immuta, the Data Provisioning Company, today introduced the first data provisioning platform for managing agentic data access. The launch includes new Agentic Data Access capabilities that enable enterprises to provision and govern AI agent access to enterprise data in real time. With Agentic Data Access, Immuta treats AI agents as first-class identities — with their own attributes, intent, temporary access, and audit trail — so they can act on behalf of users without authenticating as them, standing privileges, or ticket-driven delays.

The launch addresses a major shift in enterprise AI: agents are becoming a primary interface for interacting with enterprise data, and they need to be governed not as shadow users or generic service accounts, but as first-class actors in the data ecosystem.

AI agents are a new class of data consumer. They operate 24/7, generate queries dynamically, move across systems continuously, and expect access decisions in seconds, not days. As organizations move from AI experimentation to enterprise deployment, they need to prepare for a future where non-human identities may outnumber human users requesting access to data.

Most data provisioning models were never built for that world. Traditional approaches rely on static roles, manual approvals, and ticket-driven workflows — often routed through systems such as ServiceNow or Jira — that were designed for infrequent and predictable requests from people. In many early AI deployments, the default approach has been to let the agent log in as the user asking the question. That may be enough for a pilot. It does not work at enterprise scale.

At enterprise scale, that model breaks down quickly. It drives account sprawl because every potential AI user must be provisioned across every system an agent might touch. It increases exposure risk because teams grant broader, longer-lasting permissions to prevent agents from failing mid-task. It leads to rights inflation, especially when agents inherit the privileges of powerful users whose access far exceeds what the task requires. And it creates a muddy audit trail, because logs may show a human executed a query when the action was actually performed by an agent. In practice, it creates human-limited AI: agents stall when they hit semantic or permission walls, and the business gets less value from the systems it is trying to scale.

Immuta’s Agentic Data Access capabilities are designed to solve that problem at the authorization layer. When an agent needs data, Immuta evaluates the request against centrally defined policies based on who the agent is acting for, what data is being requested, and why it is needed. Immuta then provisions temporary access directly in the underlying data platform — such as Snowflake, Databricks, and BigQuery — granting only the access required for that task and automatically removing it when the task is complete.

How Immuta’s Agentic Data Access Works

Immuta’s Agentic Data Access capabilities extend its policy-driven data provisioning model to AI agents, enabling enterprises to govern non-human identities with the same precision as human users — and with the speed agent-driven workflows demand.

• Agents as First-Class Actors: Immuta treats AI agents as first-class actors in the data ecosystem, with their own identity, attributes, intent, and audit trail. Rather than operating through OAuth or shared credentials, agents are governed explicitly and transparently.
• Role Vending for AI Agents: When an AI agent acts on behalf of a user, Immuta dynamically generates a temporary role in the underlying data platform that reflects only the permissions the user is authorized to exercise for that specific task. This is deterministic policy enforcement at the data platform tier, unlike non-deterministic solutions at the LLM tier.
• Zero Standing Privileges: Access is provisioned just in time and removed automatically when the task is complete, reducing persistent exposure, eliminating unused credentials, and minimizing risk.
• Clear, Auditable Activity: Immuta records when an AI agent accessed data, which user it acted for, and what data was retrieved, creating a clear audit trail for governance, security, and compliance teams.

This gives enterprises a fundamentally different model for the age of agents. Instead of collapsing the agent and the user into one identity, Immuta gives them separate identities that work together. The agent acts on behalf of the user, not as the user. That reduces account sprawl, eliminates standing privileges, and creates clear accountability for when a person accessed data, when an agent acted independently, and when an agent acted on behalf of a user.

“AI agents are not just another application endpoint — they are a new identity type in the enterprise,” said Matthew Carroll, CEO of Immuta. “They are always on, they move at machine speed, and they need access in the moment. If companies keep trying to provision them through workflows built for humans, they will either bottleneck AI or overexpose sensitive data. Agentic Data Access gives them a way to move fast without giving up governance.”

The Next Era of Data Provisioning

This announcement marks the next phase in Immuta’s evolution — from separating policy from platform, to automating data provisioning, to now governing agent-driven access at machine speed. Because Immuta externalizes policy and enforces it directly within cloud data platforms, extending that model to AI agents is a natural evolution of the platform, not a reinvention.

What’s Next: From Access to Understanding

Immuta’s Agentic Data Access capabilities are the foundation for a broader shift in how data is discovered, accessed, and used. Granting the right access at the right moment is only the beginning. The next step is helping agents understand what data a user is allowed to use, how that data is defined, and how to safely request more access when needed.

Looking ahead, Immuta is extending this model in two key areas:

• Semantic Governance: Immuta will extend access awareness into the semantic layer, giving agents visibility into which metrics, fields, and relationships a user is allowed to use — and for which purposes — while enforcement continues in the underlying data platform. This helps agents plan better queries, avoid dead ends, and generate more accurate results.
• Agent-Initiated Access Requests (Question-Time Access): When additional data is required to answer a question, agents will be able to request access on behalf of users in real time. Requests can be automatically approved through deterministic policies or routed for human review when additional oversight is needed, enabling a new model of just-in-time, question-driven access provisioning.

Together, these capabilities move beyond access control to access orchestration, enabling agents to safely discover, request, and use data in a fully governed, fully auditable way at machine speed.

“We are moving into a world where more data access requests will come from agents than from people,” said Steve Touw, CTO of Immuta. “That changes the fundamentals of provisioning. The organizations that win will be the ones that can grant the right access for the right task at the right time, while preserving governance, accountability, and control. That is the future Immuta is building for.”

As AI agents become embedded across analytics, operations, and decision-making workflows, enterprises will need a new provisioning model built for both human and non-human identities. With Agentic Data Access, Immuta is delivering the foundation for that next era — and the roadmap for what comes after.

For more information on Immuta’s vision for Agentic Data Access, visit immuta.com/agentic-data-access or read our latest blog.

About Immuta
Since 2015, Immuta has helped Fortune 500 companies and government agencies put data to work faster and more safely than ever before. As organizations face exploding demand for data access provisioning from both human and AI systems, Immuta’s platform automates data provisioning and governance across complex data ecosystems. By eliminating manual processes that create access delays, Immuta helps enterprises provision secure access at unprecedented speed while maintaining continuous compliance. The company’s intelligent solutions streamline collaboration between data consumers, stewards, and governors, enabling organizations to scale data use without scaling risk. For more information, visit immuta.com.